Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 15, 2020
Outcomes of drug exposition during pregnancy: Analysis from a teratology information serviceCamille Lenoir, Sabrina Boumaïza, Kuntheavy R Ing Lorenzini, et al.
Frontiers in Pharmacology|September 13, 2021
CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical SettingKuntheavy Ing Lorenzini, Jules Desmeules, Victoria Rollason, et al.
Revue Medicale Suisse|August 10, 2012
[Pain medication during pregnancy]Miozzari Anne Catherine Pereira, Selim Senhaji, Victoria Rollason Gumprecht, et al.
The Lancet. Psychiatry|September 12, 2015
Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysisFrançois R Girardin, Antoine Poncet, Marc Blondon, et al.
The Cochrane Database of Systematic Reviews|February 27, 2016
Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)Victoria Rollason, Alexandra Laverrière, Laura C I MacDonald, et al.
Pharmacogenomics|January 24, 2015
P-glycoprotein: a clue to vitamin K antagonist stabilizationLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.
Viruses|June 27, 2024
Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric PatientsNadia Exquis, Benjamin Dionisi, Caroline Flora Samer, et al.
Clinical Pharmacology and Therapeutics|September 2, 2021
Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva CocktailCamille Lenoir, Jean Terrier, Yvonne Gloor, et al.
Pharmacogenomics|May 9, 2013
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatmentLiliane Gschwind, Victoria Rollason, Françoise Boehlen, et al.
Pageof 5